| Name | TP3011 |
|---|
| Description | TP3011 is a potent topoisomerase-1 inhibitor and is the active metabolite converted from TP3076 by aldehyde oxidase 1 (AOX1)[1]. TP3011 has robust anti-tumor activities against cancer cell lines[2]. |
|---|---|
| Related Catalog | |
| Target |
Topoisomerase I |
| In Vitro | TP3011 (0-100 nM; 72 hours) inhibits cell proliferative activities against various human cancer cell lines, producing 50% inhibition (IC50) of cell growth of 0.85 nM; 8.5 nM; and 8.2 nM in HCT116, QG56, and NCI-H460 (NSCLC) cells, respectively[2]. Cell Proliferation Assay[2] Cell Line: HCT116, QG56, and NCI-H460 (NSCLC) cells Concentration: 0-100 nM Incubation Time: 72 hours Result: Was against human cancer cell lines, such as CRC and NSCLC cell lines. |
| References |
| Molecular Formula | C26H26N4O5 |
|---|---|
| Molecular Weight | 474.51 |